Make an appointment

Amyotrophic Lateral Sclerosis (ALS) Therapy

Amyotrophic Lateral Sclerosis (ALS) Stem Cells Treatment at Swiss Medica Clinic

Amyotrophic lateral sclerosis (ALS) is a severe progressive disease of the nervous system, first isolated in 1869 by Charcot. Despite more than a century of its study, the reasons leading to ALS development remain unclear. At the given disease the degeneration of motor neurons takes place in the spinal cord and the brain, resulting in muscles motor paralysis, as the disease progresses. The disease debut lies in the development of muscle weakness what causes ALS with muscular frame atrophy. Prognosis is extremely poor. Until recently the treatment was only symptomatic, which allowed to delay fatal ending for some period.

In recent years there has been a breakthrough in the ALS therapy. Numerous studies have demonstrated how is ALS treated by the positive effect of stem cell therapy for Amyotrophic Lateral Sclerosis. SC are represented by cells that have not undergone differentiation and acquired specific functions. SC have the self-healing capacity with dividing and differentiating into specific cell types. Mature or differentiated cells used for the treatment of degenerative diseases which include amyotrophic lateral sclerosis, or, which form specific structures and perform specific functions and in many cases, lose the ability to divide and reproduce which is the basis of stem cell therapy for ALS.

The use of this innovative method increases the release level of neurotrophic substances by mesenchymal steam cell therapy. The neurotrophic substances protect motor neurons against damages, contribute to its formation and improve the neuromuscular interaction. This is the first therapy of mesenchymal stem cells use. The method basis lies in the use of patient bone marrow SC which uses for the neurons growing in the laboratory, followed by the complex administration of neuronal and mesenchymal SC by lumbar puncture or intravenously. The entire treatment process takes place on the highest technological and medical standards. The risk of treatment by Adult Autologous Stem Cell is minimal and limited to the normal risks of surgical intervention. Because the used cells are of patient's own, the rejection reaction, as during implantation of foreign cells and organs is excluded. The treatment by own steam cells can significantly slow the ALS symptoms and thereby prolong the patient life. The limbs movement increase, muscle tension decrease, reflexes normalization, fasciculations zones number decrease, better tolerability of daily stress, swallowing improving with diction and clarity of words pronunciation observes in the majority of patients after transplantation.

ALS stem cell therapy opens entirely new possibilities in the disease treatment, resulting in the significant improvement of patient’s motor activity with mental and emotional status. Numerous clinical trials and personal experience of the clinic ALS treatment using autologous hematopoietic SC proved the absolute technology safety. Furthermore, the clinical method efficacy gives reason to believe not only in the future treatment of amyotrophic lateral sclerosis, but the Alzheimer's. The only hope in the Amyotrophic Lateral sclerosis stem cell therapy lies in the use of SC, which are able to repair damaged brain areas. Currently, stem cells therapy can be considered the most modern and effective treatment method of amyotrophic lateral sclerosis, which has been successfully applied in practice and in famous European clinic SwissMedica.

Get More Information About ALS >>>


The following is a list of diseases treated by stem cell therapy in the well-known European Clinic SwissMedica:

  • Erectile dysfunction;
  • Amyotrophic lateral sclerosis;
  • Alzheimer disease;
  • Parkinson's disease;
  • Macular degeneration;
  • Diabetes (type 1 and 2)
  • Apoplexy;
  • Spinal cord injury;
  • Multiple sclerosis;
  • Cardiovascular disease;
  • Cerebral paralysis;
  • Orthopedic diseases

SwissMedica has a great successful clinical experience in helping patients with neurodegenerative disorder such as Amyotrophic Lateral Sclerosis (ALS). Patient's conditions with such disease varies greatly (paralysis, paraplegia, disturbances in speech, motor and sensory functions and etc). More than 90% of such patients have the improvements. The level of individual patient's success strongly depend on many factors (history of the disease, current sate, previous treatment, age, co-exiting disease and etc.) It is better to start treatment as soon as possible as time influence greatly on the efficiency of the therapy.

Usually Amyotrophic Lateral Sclerosis NeuroRegenerative treatment programs are long lasting and individually composed like in used therapeutic procedures so in duration and frequency. 

As autologous mesenchymal stem cells therapy has proved it's clinical efficacy for patients with neurodegenerative processes it is obviously included in every treatment program.

One course Amyotrophic Lateral Sclerosis NeuroRegenerative treatment program may last 3 or 12  days.  

Get More Information About Safety of Mesenchymal Stem Cells Therapy in Swiss Medica Clinic>>>

Download PDF "Stem Cells Therapy at Swiss Medica” here ►